Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00145314
Status:
COMPLETED
Last Update Posted:
2011-01-14
First Post:
2005-09-02
Brief Title:
FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer
Sponsor:
The Nordic Colorectal Cancer Biomodulation Group
Organization:
The Nordic Colorectal Cancer Biomodulation Group
Organization Data
Organization:
The Nordic Colorectal Cancer Biomodulation Group
Class:
OTHER
Study ID:
Nordic VII
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Nordic Colorectal Cancer Biomodulation Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Kjell M Tveit MD PhD
Old Organization:
The Nordic Colorectal Cancer Biomodulation Group